Promyelocytic Leukemia Gene Functions and Roles in Tumorigenesis

被引:4
|
作者
Imani-Saber, Zeinab [1 ]
Ghafouri-Fard, Soudeh [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran
关键词
PML; cancers; structure; nuclear bodies; functions and; physiological roles; PML NUCLEAR-BODIES; TUMOR-SUPPRESSOR PML; RAR-ALPHA; MEDIATED DEGRADATION; CANCER-CELLS; DNA-DAMAGE; BREAST-CANCER; PROTEIN; IMMUNOTHERAPY; SENESCENCE;
D O I
10.7314/APJCP.2014.15.19.8021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The promyelocytic leukemia (PML) gene is a gene known to be a tumor suppressor, although recent data suggest that it has a dual function in tumorigenesis. It was initially discovered in acute promyelocytic leukemia (APL) in which a t(15; 17) chromosomal translocation fused it to the retinoic acid receptor alpha (RAR alpha). It has been shown to be involved in various types of cancer. It has at least 6 nuclear isoforms and a cytoplasmic type with different characteristics. Its multiple functions in growth inhibition, apoptosis induction, replicative senescence, inhibition of oncogenic transformation, and suppression of migration and angiogenesis have made it a therapeutic target for cancer therapy. However, its dual role in the process of tumorigenesis has made this field challenging. In this review, we discuss PML structure, functions and expression in tumors.
引用
收藏
页码:8021 / 8028
页数:8
相关论文
共 50 条
  • [1] Functions and dys-functions of promyelocytic leukemia protein PML
    Previati, Maurizio
    Missiroli, Sonia
    Perrone, Mariasole
    Caroccia, Natascia
    Paliotto, Federico
    Milani, Daniela
    Giorgi, Carlotta
    RENDICONTI LINCEI-SCIENZE FISICHE E NATURALI, 2018, 29 (02) : 411 - 420
  • [2] Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression
    Munkhjargal, Anudari
    Kim, Myung-Jin
    Kim, Da-Yeon
    Jeon, Young-Jun
    Kee, Young-Hoon
    Kim, Lark-Kyun
    Kim, Yong-Hwan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [3] Promyelocytic leukemia protein (PML) and stem cells: from cancer to pluripotency
    Vogiatzoglou, Amalia P.
    Moretto, Fabien
    Makkou, Maria
    Papamatheakis, Joseph
    Kretsovali, Androniki
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2022, 66 (1-3) : 85 - 95
  • [4] Acute promyelocytic leukemia, arsenic, and PML bodies
    de The, Hugues
    Le Bras, Morgane
    Lallemand-Breitenbach, Valerie
    JOURNAL OF CELL BIOLOGY, 2012, 198 (01) : 11 - 21
  • [5] Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen
    Chung, Yih-Lin
    Wu, Mei-Ling
    ONCOTARGET, 2016, 7 (19) : 28393 - 28407
  • [6] Functions and dys-functions of promyelocytic leukemia protein PML
    Maurizio Previati
    Sonia Missiroli
    Mariasole Perrone
    Natascia Caroccia
    Federico Paliotto
    Daniela Milani
    Carlotta Giorgi
    Rendiconti Lincei. Scienze Fisiche e Naturali, 2018, 29 : 411 - 420
  • [7] Targeting Promyelocytic Leukemia Protein: A Means to Regulating PML Nuclear Bodies
    Reineke, Erin L.
    Kao, Hung-Ying
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (04): : 366 - 376
  • [8] History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies
    Bercier, Pierre
    de The, Hugues
    CANCERS, 2024, 16 (07)
  • [9] Germline variants of the promyelocytic leukemia tumor suppressor gene in patients with familial cancer
    Plevova, P.
    Walczyskova, S.
    Jeziskova, I.
    Jurckova, N.
    Krepelova, A.
    Puchmajerova, A.
    Pavlikova, K.
    Foretova, L.
    Zapletalova, J.
    Silhanova, E.
    NEOPLASMA, 2009, 56 (06) : 500 - 507
  • [10] Role of Promyelocytic Leukemia Protein in Host Antiviral Defense
    Geoffroy, Marie-Claude
    Chelbi-Alix, Mounira K.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (01) : 145 - 158